|
TWST: Would you give us a brief historical sketch of the company and a
picture of the things you are doing right now?
Mr.McManus: Right now, we are building an ultrasonic medical device
platform that is not for imagery; rather, it is used therapeutically. As
you know, ultrasound has been used for imagery for 30 years or so. What
we are doing is applying that technology for therapeutic purposes, such
as laparoscopic surgery, liposuction, neurosurgery, and, through
advanced research and development, for killing of cancerous tissue in
the kidney, liver, and breast. So basically since 1999, we have been
trying to develop new products that can make a difference in a variety
of medical treatments ' products that are a platform unlike any that
anybody else in the world has that we know of. We have created medical
devices that are used in very large markets like bone cutting, wound
debridement and cancer. TWST: What are the main products that you have developed so far?
Mr.McManus: We have developed a product for laparoscopic surgery, a
product for liposuction, a product for neurosurgery, a product for
lithotripsy, a product for prostate cancer, and, now, a product for
kidney cancer that also can be leveraged for the treatment of cancer in
most soft tissues of the human body.
Tickers included in this excerpt: MSON
For more information call (212) 952 7433. The
Wall Street Transcript does not endorse any of the comments made by interviewees, and does
not make stock recommendations.
|
|
